Search research articles
Contact Us
Filters
Showing results (111-120 of 513) with videos related to
Page
of 52
Sort By:
Journal of Surgical Oncology
|
August 23, 2016
Prognostic significance of clinical and <sup>18</sup> F-FDG PET/CT parameters for post-distant metastasis survival in head and neck squamous cell carcinoma patients
Jae-Keun Cho, Seung Hyup Hyun, Joon Young Choi, et al.
Lung Cancer (Amsterdam, Netherlands)
|
June 24, 2014
The presence of extrathoracic metastasis is more prognostic of survival than Masaoka stage (IVa/IVb) in metastatic thymic epithelial tumor: a retrospective cohort study
Dong-Yeop Shin, Dong-Wan Kim, Bhumsuk Keam, et al.
Molecular Medicine Reports
|
April 12, 2011
A Phase II study of 5-fluorouracil and cisplatin systemic chemotherapy for inoperable hepatocellular carcinoma with α fetoprotein as a predictive and prognostic marker
Bhumsuk Keam, Do-Youn Oh, Se-Hoon Lee, et al.
Neuropathology : Official Journal of the Japanese Society of Neuropathology
|
December 16, 2014
IDH2 mutation in gliomas including novel mutation
Jaemoon Koh, Hwajin Cho, Hannah Kim, et al.
Oncotarget
|
November 3, 2015
Genomic dynamics associated with malignant transformation in IDH1 mutated gliomas
Chul-Kee Park, Inho Park, Seungmook Lee, et al.
Investigational New Drugs
|
May 25, 2019
Entrectinib resistance mechanisms in ROS1-rearranged non-small cell lung cancer
Bo Mi Ku, Yeon Hee Bae, Kyoung Young Lee, et al.
Cancer Research and Treatment
|
November 2, 2021
A Single-Arm, Prospective, Phase II Study of Cisplatin Plus Weekly Docetaxel as First-Line Therapy in Patients with Metastatic or Recurrent Salivary Gland Cancer
Hye Ryeon Kim, Su Jin Lee, Sehhoon Park, et al.
International Journal of Clinical Oncology
|
August 6, 2013
Rare and complex mutations of epidermal growth factor receptor, and efficacy of tyrosine kinase inhibitor in patients with non-small cell lung cancer
Bhumsuk Keam, Dong-Wan Kim, Jin Hyun Park, et al.
Cancer Chemotherapy and Pharmacology
|
July 23, 2017
Comparison of RECIST to immune-related response criteria in patients with non-small cell lung cancer treated with immune-checkpoint inhibitors
Hee Kyung Kim, Mi Hwa Heo, Han Sang Lee, et al.
Lung Cancer (Amsterdam, Netherlands)
|
May 3, 2016
Assessment of objective responses in thymic epithelial tumors using ITMIG modified criteria
Hae Su Kim, Ji Yun Lee, Sung Hee Lim, et al.
Page
of 52
Search research articles
Search
Showing results (111-120 of 513) with videos related to
Sort By:
Page
of 52
Journal of Surgical Oncology
|
August 23, 2016
Prognostic significance of clinical and <sup>18</sup> F-FDG PET/CT parameters for post-distant metastasis survival in head and neck squamous cell carcinoma patients
Jae-Keun Cho, Seung Hyup Hyun, Joon Young Choi, et al.
Lung Cancer (Amsterdam, Netherlands)
|
June 24, 2014
The presence of extrathoracic metastasis is more prognostic of survival than Masaoka stage (IVa/IVb) in metastatic thymic epithelial tumor: a retrospective cohort study
Dong-Yeop Shin, Dong-Wan Kim, Bhumsuk Keam, et al.
Molecular Medicine Reports
|
April 12, 2011
A Phase II study of 5-fluorouracil and cisplatin systemic chemotherapy for inoperable hepatocellular carcinoma with α fetoprotein as a predictive and prognostic marker
Bhumsuk Keam, Do-Youn Oh, Se-Hoon Lee, et al.
Neuropathology : Official Journal of the Japanese Society of Neuropathology
|
December 16, 2014
IDH2 mutation in gliomas including novel mutation
Jaemoon Koh, Hwajin Cho, Hannah Kim, et al.
Oncotarget
|
November 3, 2015
Genomic dynamics associated with malignant transformation in IDH1 mutated gliomas
Chul-Kee Park, Inho Park, Seungmook Lee, et al.
Investigational New Drugs
|
May 25, 2019
Entrectinib resistance mechanisms in ROS1-rearranged non-small cell lung cancer
Bo Mi Ku, Yeon Hee Bae, Kyoung Young Lee, et al.
Cancer Research and Treatment
|
November 2, 2021
A Single-Arm, Prospective, Phase II Study of Cisplatin Plus Weekly Docetaxel as First-Line Therapy in Patients with Metastatic or Recurrent Salivary Gland Cancer
Hye Ryeon Kim, Su Jin Lee, Sehhoon Park, et al.
International Journal of Clinical Oncology
|
August 6, 2013
Rare and complex mutations of epidermal growth factor receptor, and efficacy of tyrosine kinase inhibitor in patients with non-small cell lung cancer
Bhumsuk Keam, Dong-Wan Kim, Jin Hyun Park, et al.
Cancer Chemotherapy and Pharmacology
|
July 23, 2017
Comparison of RECIST to immune-related response criteria in patients with non-small cell lung cancer treated with immune-checkpoint inhibitors
Hee Kyung Kim, Mi Hwa Heo, Han Sang Lee, et al.
Lung Cancer (Amsterdam, Netherlands)
|
May 3, 2016
Assessment of objective responses in thymic epithelial tumors using ITMIG modified criteria
Hae Su Kim, Ji Yun Lee, Sung Hee Lim, et al.
Page
of 52